# US 2026/0043066 A1 · Compositions and methods related to kethoxal derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0043066 A1
- Document ID: US20260043066A1
- Status: Published application
- Kind: A1
- Application number: 19/302,667
- Filed: 2025-08-18
- Published: 2026-02-12
- Earliest claimed: 2018-05-08
- Assignees: The University of Chicago
- Applicants: The University of Chicago
- Inventors: Chuan HE; Xiaocheng WENG; Tong WU
- Web page: https://patentgrep.com/patent/US20260043066A1

## CPC

- C07C 247/04: being saturated
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C07C 69/003: Esters of saturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 2830/46: elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
- C12Q 2565/518: characterised by the immobilisation of the nucleic acid sample or target
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Embodiments are directed to N3-kethoxal reagents and derivatives thereof, and related methods that allow fast and reversible labeling of single-stranded nucleic acids in live cells. By way of example, one aspect is directed to a process for reversible labeling of single-stranded guanine bases in live cells, which results in an effective in vivo method for transcriptome-wide RNA secondary structure mapping and RNA G-quadruplex prediction.

## Claims

### Claim 1

A compound having the formula:
wherein Y is a click chemistry moiety selected from alkynes, azides, strained alkynes, dienes, dieneophiles, alkoxyamines, carbonyls, phosphines, hydrazides, thiols, and alkenes; and
X is a linker.

### Claim 2 (depends on 1)

The compound of claim 1, wherein X is azide.

### Claim 3 (depends on 1, 2)

The compound of claim 1 or 2, wherein the linker is a C1 to C10 alkyl or polyethylene glycol linker.

### Claim 4 (depends on 1, 2, 3)

The compound of any one of claims 1 to 3, wherein Y is CH2.

### Claim 5

A compound having the formula:

### Claim 6 (depends on 1)

A method for labeling a guanine base comprising, contacting a guanine to be labeled with a compound of claim 1 to form a reaction mixture and incubating the reaction mixture at 30 to 40° C. for at least 5 minutes.

### Claim 7 (depends on 6)

The method of claim 6, wherein the compound is N3-kethoxal.

### Claim 8 (depends on 6, 7)

The method of claim 6 or 7, wherein the guanine is further comprised in polynucleotide.

### Claim 9 (depends on 8)

The method of claim 8, wherein the polynucleotide is a ribonucleic acid (RNA).

### Claim 10 (depends on 8)

The method of claim 8, wherein the polynucleotide is a deoxyribonucleic acid (DNA).

### Claim 11 (depends on 9)

The method of claim 9, wherein the RNA is an RNA transcript.

### Claim 12 (depends on 1)

A method for labeling a single stranded nucleic acid in a cell comprising
(i) contacting a target cell with a compound of claim 1 to form a treated cell comprising a nucleic acid having kethoxal derivative-labeled guanine bases;
(ii) contacting the treated cell with a crosslinking moiety comprising at least two click chemistry reactive moieties and a tag, wherein the crosslinking moiety crosslinks two proximal kethoxal derivative-labeled guanines to form a crosslinked nucleic acid; and
(iii) fragmenting and isolating the crosslinked nucleic acid using a reagent with an affinity for the tag.

### Claim 13 (depends on 12)

The method of claim 12, wherein the tag is biotin.

### Claim 14 (depends on 13)

The method of claim 13, wherein the reagent with an affinity for the tag is streptavidin.

### Claim 15 (depends on 12, 13, 14)

The method of any one of claims 12 to 14, wherein the click chemistry reactive moieties are dibenzocyclooctyne moieties.

### Claim 16 (depends on 12, 13, 14, 15)

The method of any one of claims 12 to 15, wherein the crosslinked nucleic acid comprises two or more nucleic acids.

### Claim 17 (depends on 12, 13, 14, 15, 16)

The method of any one of claims 12 to 16, wherein the crosslinked nucleic acid is RNA.

### Claim 18

A method for in vivo transcriptome-wide RNA secondary structure mapping and RNA G-quadruplex prediction comprising the steps of:
(a) labeling a nucleic acid in vivo with a kethoxal click chemistry derivative;
(b) biotinylating the labeled nucleic acid;
(c) fragmenting the labeled and biotinylated nucleic acid;
(d) synthesizing complementary DNA (cDNA) from the fragmented/biotinylated nucleic acid;
(e) isolating the synthesized cDNA associated with biotinylated nucleic acid;
(f) separating cDNA based on size;
(g) performing cyclization of the separated cDNA to form a cyclized cDNA library; and
(h) amplifying the cyclized cDNA library.

### Claim 19 (depends on 18)

The method of claim 18, wherein cyclization of cDNA comprises ligation of the cDNA with a single-stranded DNA ligase.

### Claim 20 (depends on 18)

The method of claim 18, wherein amplifying the cyclized cDNA library comprises polymerase chain reaction (PCR).

### Claim 21

A method for analyzing RNA/protein interaction directed to kethoxal derivative protein crosslinking comprising:
(a) contacting a protein target in proximity to RNA with a kethoxal derivative coupled to an activatable protein crosslinking moiety forming a target/kethoxal derivative mixture;
(b) exposing the target/kethoxal derivative mixture to an activator to activate the protein crosslinking moiety and forming a crosslinked target/kethoxal derivative complex;
(c) isolating the crosslinked target/kethoxal derivative complex using an affinity agent that binds the protein target; and
(d) identifying RNAs isolated with target/kethoxal derivative complex.

### Claim 22 (depends on 21)

The method of claim 21, wherein the activatable crosslinking moiety is disuccinimidyl glutarate, disuccinimidyl suberate, disuccinimidyl tartrate, dimethyl adipimidate, dimethyl pimelimidate, dimethyl suberimidate, 1,5-difluoro-2,4-dinitrobenzene, N-maleimidopropionic acid hydrazide, 3-(2-pyridyldithio)propionyl hydrazide, bismaleimidoethane, diazarine, succinimidyl iodoacetate, N-maleimidoacet-oxysuccinimide ester, succinimidyl 3-(2-pyridyldithio)propionate or benzophenone.

### Claim 23 (depends on 21, 22)

The method of any one of claims 21 to 22, wherein the activator is light.

### Claim 24 (depends on 23)

The method of claim 23, wherein the light is ultraviolet light.

### Claim 25 (depends on 24)

The method of claim 24, wherein the light has a wavelength of about 350 to 375 nm.

### Claim 26 (depends on 25)

The method of claim 25, wherein the light comprises a wavelength of 365 nm.

### Claim 27

A method for synthesizing azido-kethoxal (N3-kethoxal) comprising the following steps:
(a) producing a 2-(2-azidoethoxy)propanoic acid intermediate by (i) combining Sodium hydride with 2-azidoethanol in tetrahydrofuran (THF) to form a first intermediate mixture, (ii) adding ethyl 2-bromopropionate to the first intermediate mixture to form a first reaction mixture, (iii) incubating the first reaction mixture under nitrogen (N2) atmosphere at room temperature forming 2-(2-azidoethoxy)propanoic acid, (iv) quenching the reaction with water, (v) adding 2-(2-azidoethoxy)propanoic acid to a LiOH aqueous solution and incubating at room temperature, and (vi) washing, isolating, and drying 2-(2-azidoethoxy)propanoic acid over anhydrous Na2SO4;
(b) producing a 3-(2-azidoethoxy)-1-diazopentane-2-one intermediate by (i) dissolving 2-(2-azidoethoxy)propanoic acid in anhydrous CH2Cl2 and dimethylformamide (DMF), (ii) adding oxalyl chloride and stirring at room temperature, (iii) removing the solvent and excess oxalyl chloride forming a residue, (iv) dissolving the residue in anhydrous CH3CN and (Trimethylsilyl)diazomethane, (v) adding diethyl ether dropwise forming a second reaction mixture, (vi) stirring the second reaction mixture at 0° C. overnight, (vii) evaporating the solvent and isolating 3-(2-azidoethoxy)-1-diazopentane-2-one; and
(c) producing N3-kethoxal or 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one by (i) adding 3-(2-azidoethoxy)-1-diazopentane-2-one to dimethyldioxirane in acetone (DMD-acetone) forming a third reaction mixture (ii) stirring the third reaction mixture at room temperature forming N3-kethoxal or 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one, and (iii) isolating N3-kethoxal or 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one.
